/AYURF
AYURF Stock - Ayurcann Holdings Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.01-41.01%
$0.01 (-41.01%) • Dec 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.50
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AYURF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.02
STOP LOSS$0.01
RISK/REWARD1:1.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.74
52W High$0.03
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $31.11M | $25.16M | $12.49M | $9.39M | $7.63M |
| Gross Profit | $10.16M | $8.46M | $3.68M | $2.22M | $4.63M |
| Gross Margin | 32.7% | 33.6% | 29.5% | 23.7% | 60.6% |
| Operating Income | $-2,823,013 | $-3,251,000 | $-5,343,603 | $-3,332,209 | $2.16M |
| Net Income | $-3,485,784 | $-3,968,000 | $-5,307,125 | $-3,087,907 | $-278,360 |
| Net Margin | -11.2% | -15.8% | -42.5% | -32.9% | -3.6% |
| EPS | $-0.01 | $-0.02 | $-0.04 | $-0.03 | $-0.00 |
Company Overview
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers end-to-end outsourcing solutions, including extraction and refinement, bulk distillate oil sales, formulation and white label manufacturing, and fulfillment and distribution, as well as customized packaging solutions and inventory management services. It also provides medicinal cannabis, such as tincture, vapes, and topicals. In addition, the company operates Ayurcann marketplace, an online cannabis market for medical cannabis consumers. The company was founded in 2018 and is headquartered in Pickering, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AYURFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q2 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 14, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q4 2025 | Nov 28, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 16, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 27, 2024 | — | — | — | — |
Q4 2024 | Oct 25, 2024 | — | — | — | — |
Q2 2024 | May 27, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | — | $-0.00 | — | — |
Q4 2023 | Oct 31, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 29, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 29, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 26, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 22, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 29, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.01 | — | — |
Q2 2021 | May 18, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AYURF
What is AYURF's current stock price?
Ayurcann Holdings Corp. (AYURF) is currently trading at $0.01 per share. The stock has moved -41.01% today.
What is the analyst price target for AYURF?
No analyst price targets are currently available for this stock.
What sector is Ayurcann Holdings Corp. in?
Ayurcann Holdings Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is AYURF's market cap?
Ayurcann Holdings Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AYURF pay dividends?
No, Ayurcann Holdings Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAYRWF
Ayr Wellness Inc.
$0.05
Mkt Cap: $0.0B
BGXX
Bright Green Corporation
$0.04
Mkt Cap: $0.0B
CBIH
Cannabis Bioscience International Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CLCFF
Christina Lake Cannabis Corp.
$0.03
Mkt Cap: $0.0B
CRRTF
Crescita Therapeutics Inc.
$0.02
Mkt Cap: $0.0B
CVSI
CV Sciences, Inc.
$0.07
Mkt Cap: $0.0B
DHBUF
Delivra Health Brands Inc.
$0.18
Mkt Cap: $0.0B
IONKF
Ionic Brands Corp.
$0.00
Mkt Cap: $0.0B
LOBEF
Lobe Sciences Ltd.
$0.00
Mkt Cap: $0.0B
TWSI
Tristar Wellness Solutions Inc.
$0.17
Mkt Cap: $0.0B
Explore stocks similar to AYURF for comparison